Dr. Allan B. Goldstein

"With Connections, members will find the tools and support to help them make informed health care decisions they feel good about, while strengthening their relationship with their doctors," said Allan Goldstein, MD, vice president and regional medical director at AmeriHealth.

strengthening their relationship with their doctors," said Allan Goldstein, MD, vice president and regional medical director at AmeriHealth."Crohn's

"With Connections, members will find the tools and support to help themmake informed health care decisions they feel good about, while strengtheningtheir relationship with their doctors," said Allan Goldstein, MD, vicepresident and regional medical director at AmeriHealth.

"With Connections, members will find the tools and support to help them make informed health care decisions they feel good about, while strengthening their relationship with their doctors," said Allan Goldstein

, MD, vice president and regional medical director at AmeriHealth.

U.S. Food and Drug Administration (FDA)," said Dr. Allan B. Goldstein, AmeriHealth New Jersey's Vice President and Regional Medical Director."But they typically cost 30 to 70 percent less than comparable brand-name drugs. "We will continue to cover a wide spectrum of FDA-approved brand and generic drugs in our formulary to provide members with ample choice in their drug benefit," said Goldstein.

"Generic drugs are identical in composition and quality to their brand-name counterparts and meet the same health and safety standards set by the U.S. Food and Drug Administration (FDA)," said Dr. Allan B. Goldstein, AmeriHealth New Jersey's Vice President and Regional Medical Director. "But they typically cost 30 to 70 percent less than comparable brand-name drugs."

"We will continue to cover a wide spectrum of FDA-approved brand and generic drugs in our formulary to provide members with ample choice in their drug benefit," said Goldstein.

Dr. Allan B. Goldstein, AmeriHealth Insurance Company of New Jersey's vice president and regional medical director said, "This 'No Pay Copay' waiver is an opportunity for our members to talk to their physicians and pharmacists about whether switching to a generic drug might be an appropriate option for them.

said Allan Goldstein, MD, vice president and regional medical director at AmeriHealth.

"Generic drugs are identical in composition and quality to their brand- name counterparts and meet the same health and safety standards set by the U.S. Food and Drug Administration (FDA)," said Dr. Allan B. Goldstein, AmeriHealth New Jersey's Vice President and Regional Medical Director."But they typically cost 30 to 70 percent less than comparable brand-name drugs.

"We will continue to cover a wide spectrum of FDA-approved brand and generic drugs in our formulary to provide members with ample choice in their drug benefit," said Goldstein.

Allan Goldstein MDRegional Medical Director